Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
ASSETS
Cash and cash equivalents
Accounts receivable, net
Inventories
Income taxes receivable
Pension plan assets
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, net
Goodwill
Other intangibles, net
Deferred income taxes
Retirement plan assets
Other long-term assets
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Accounts payable
Accrued expenses and other liabilities
Total current liabilities
Retirement plan liabilities
Other long-term liabilities
Total liabilities
Stockholders' Equity
Common stock, $0.10 par value, 74,000,000 shares authorized, issued and outstanding - 35,234,398 shares in 2026 and 34,998,034 shares in 2025
Retained earnings
Accumulated other comprehensive loss
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support